Nasal delivery devices Market is expected to reach US$ 95,676.62 Mn by 2027

PRESS RELEASE BY The Insight Partners 19 Oct 2020

Share this press on

Nasal Delivery Devices Market for Inhalers toGrow at Highest CAGR During 2020–2027


According to our new market research study on “Nasal Delivery Devices Market to 2027 – Global Analysis and Forecast – by Drug Type, Delivery Technologies, and End User,” the market is expected to reach US$ 95,676.62 million by2027 from US$ 58,502.18 million in 2019. The market is estimated to grow with a CAGR of 6.4% from 2020 to 2027. The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth.


Based on delivery technologies, the market is segmented in to spray, nebulizers, inhalers, and others. In 2019, the inhalerssegment held the largest share of the market and is expected to grow at the fastest CAGR during the forecast period.An inhaler (also known as a pump, puffer, or allergy spray) is a nasal delivery device used for delivering medicines into the lungs via person's breathing mechanism. This device helps deliver medical treatment to the targeted region of the body, thereby reducing the side effects of oral medications. There are a wide variety of inhalers that are used to treat numerous medical conditions, such as asthma and chronic obstructive pulmonary disease (COPD). Some of the common types of inhalers include meter-dosed inhalers, dry powder inhalers, soft mist inhalers, and others. There are certain types of inhalers containing drugs in it for the treatment of asthma and COPD such as, reliever inhalers: contain bronchodilator medicines, preventer inhalers: contain a steroid medicine.


GlaxoSmithKline plc.;AstraZeneca; Pfizer Inc.; BD; Sanofi; Merck & Co., Inc.; Cadila Pharmaceuticals Ltd.; Novartis AG; Dr. Reddy's Laboratories;and Neurelis, Inc.are among the leading companies operating in the nasal delivery devices market.


Nasal Delivery Devices Market, by Region, 2019 (%)

Nasal Delivery Devices Market, by Region, 2019 (%)

Nasal delivery devices Market to Grow at a CAGR of 6.4% to reach US$ 95,676.62 Million from 2020 to 2027

Download Free Sample

Nasal delivery devices Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Drug Type (Anesthetics, Antibiotics, Pain Relief Drugs, Calcium Supplements, Vasoconstrictors, Antihistamines, and Others); Delivery Technologies (Spray, Nebulizers, Inhalers, and Others); End User (Home Care, Settings, Hospitals, and Clinics), and Geography


The Report Segments Global Nasal Delivery Devices Market as Follows:


By Drug Type

  • Anaesthetics
  • Antibiotics
  • Pain Relief Drugs
  • Calcium Supplements
  • Vasoconstrictors
  • Antihistamines
  • Others

By Delivery Technologies

  • Spray
  • Nebulizers
  • Inhalers
  • Others

By End User

  • Home Care Settings
  • Hospitals
  • Clinics

By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Rest of APAC
  • Middle East and Africa (MEA)
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of MEA
  • South and Central America (SCAM)
    • Brazil
    • Argentina
    • Rest of SCAM

Contact Us
Phone: +1-646-491-9876
Download Free PDF Brochure